Symposia
Adult- Health Psychology / Behavioral Medicine
Nicholas J. Beimer, M.D.
Clinical Associate Professor
Department of Neurology, University of Michigan, Ann Arbor
Ann Arbor, MI, United States
Najda Robinson-Mayer, MSW (she/her/hers)
Licensed Clinical Social Worker
Department of Neurology and Department of Social Work, University of Michigan, Ann Arbor
Ann Arbor, MI, United States
Elissa Patterson, Ph.D. (she/her/hers)
Clinical Assistant Professor
Department of Psychiatry, Neurology, University of Michigan, Ann Arbor
Ann Arbor, MI, United States
Gerald Scott Winder, MD
Board Certified Psychiatrist
Henry Ford Health
Detroit, MI, United States
Wesley Kerr, M.D., Ph.D.
Assistant Professor of Neurology and Bioinformatics
Department of Neurology, University of Pittsburgh
Ann Arbor, MI, United States
Otherwise known as psychogenic nonepileptic seizures (PNES), functional seizures
(FS) are associated with substantial decreases in quality of life, increases in healthcare
utilization, and increased mortality rate. While there are some trials demonstrating the impact of neurobehavioral treatment, there is limited real-world evidence. To begin to gauge the impact of a holistic multidisciplinary FS treatment clinic, we evaluated the changes in seizure frequency
from diagnosis through treatment and follow-up. We evaluated 179 patients referred to the multidisciplinary FS clinic at one Comprehensive Epilepsy Center. We performed retrospective chart review to track seizure frequency at diagnosis, evaluation for therapy, throughout the course of therapy, and up to 12- months after onset of therapy or diagnosis, both for patients who underwent therapy and those who did not. We evaluated the changes in seizure frequency, relative to diagnosis, throughout treatment and 12-month follow-up. At the post-diagnosis evaluation visit, which was before starting therapy, seizure frequency compared to at diagnosis was variable, with 50% having more seizures and 50% having less frequent seizures, including 16% seizure freedom. At the last therapy visit completed, the 50% of patients had half as many seizures, 30% of patients were seizure free, and, conversely, 35% had a higher seizure frequency than when they were diagnosed. For 42 of these patients with 12-month follow up, the median reduction in seizure frequency was 80%, including 39% of patients were seizure free and, conversely, 25% had a higher seizure frequency than when they were diagnosed. Diagnosis without treatment was not consistently associated with a reduction in seizure frequency. Most patients who underwent treatment had a substantial reduction in seizure frequency. However, 12-months after diagnosis, only 39% of patients were seizure free.